LD-2 disclosure · 4th Quarter - Termination
VIATRIS INC
Client
- Name
- VIATRIS INC
- Description
- Generics and specialty pharmaceutical company.
- Location
- Pennsylvania · United States of America
Registrant
- Description
- Government relations consulting.
- Location
- Washington, District of Columbia, United States of America
Lobbying activities
4 issuesPharmacy
Issues related to e-labeling.
LobbyistsMALLOY MCDANIEL · KRISTI REMINGTON · ASHLEY DAVIS · SHIMON STEIN · CRAIG KALKUT · CHRISTOPHER BUKI
TargetedSENATE · HOUSE OF REPRESENTATIVES
Health Issues
Issues related to drug pricing; issues related to pharmaceutical supply chain; issues related to modernization of prescribing information for physicians and pharmacists; Improved Access to Affordable Medications Act, S. 1120; Increasing Transparency in Generic Drug Applications, S.775 and HR 3839; Part D Formulary Design and Generic Drug Tiering; Prescription Information Modernization Act, HR 1503.
LobbyistsMALLOY MCDANIEL · KRISTI REMINGTON · ASHLEY DAVIS · SHIMON STEIN · CRAIG KALKUT · CHRISTOPHER BUKI
TargetedSENATE · HOUSE OF REPRESENTATIVES
Copyright/Patent/Trademark
Issues related to Inter Partes Review and patent policy generally; Preserve Access to Affordable Generics and Biosimilars Act, S.142; Affordable Prescriptions for Patients Act, S. 150 Issues related to FDA and PTO coordination, including, Interagency Patent Coordination and Improvement Act of 2023, S. 79 and HR 1717, and Medication Affordability and Patent Integrity Act, S.2780 and HR 5429; PREVAIL Act, S.2220 and HR 4370; Patent Eligibility Restoration Act of 2023, S.2140.